Yardley, PA, United States of America

Craig R Fairchild


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Craig R. Fairchild

Introduction

Craig R. Fairchild, an esteemed inventor based in Yardley, Pennsylvania, has made significant strides in the field of biochemistry and drug development. With a portfolio of five patents, he has been instrumental in the discovery of novel compounds and predictive markers that show promise in the realm of cancer treatment.

Latest Patents

One of Craig's notable patents focuses on cytotoxic xanthone compounds. This invention relates to xanthone compounds isolated from the Madagascar plant, Hochr. (Clusiaceae), which exhibit potent cytotoxic properties. His work in this area could pave the way for new therapeutic options in oncology. Another significant patent involves the identification of polynucleotides that predict the activity of compounds interacting with protein tyrosine kinases in breast cells. This invention identifies specific polynucleotide marker sets that can aid in predicting drug response and serve as diagnostic indicators for breast cancer management, particularly regarding the resistance and sensitivity of breast cell lines to treatment.

Career Highlights

Craig has had an impressive career, contributing to major companies in the pharmaceutical and research sectors. He worked for Bristol-Myers Squibb Company, where he engaged in research that aligns with his patent work. Additionally, as part of the University of Utah Research Foundation, he has furthered research initiatives aimed at understanding cancer pathways and developing innovative therapies.

Collaborations

Throughout his career, Craig has collaborated with notable colleagues, including Fei Huang and Xia Han. Their joint efforts have focused on advancing research in cancer-related fields and enhancing the efficacy of treatments available for patients.

Conclusion

In summary, Craig R. Fairchild exemplifies the spirit of innovation in the field of biotechnology. His patents are a testament to his dedication and expertise, contributing valuable knowledge and resources that could significantly impact the future of cancer treatment. As he continues his work, the scientific community eagerly anticipates more breakthroughs stemming from his research contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…